Evidence map›Paper›PMID 30618112›Full record

Trial reportJournal of diabetes investigation2019

Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes.

Jung Hye Kim, Kahui Park, Sang Bae Lee, Shinae Kang, Jong Suk Park, Chul Woo Ahn, Ji Sun Nam

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Journal of diabetes investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. COVID-19 vaccines and blood glucose control: Friend or foe?Human vaccines & immunotherapeutics · 2024
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jung Hye KimDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.
Kahui ParkDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.
Sang Bae LeeDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.
Shinae KangDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.
Jong Suk ParkDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-5385-1373
Chul Woo AhnDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.
Ji Sun NamDivision of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-8655-5258
Yonsei University · KRGangnam Severance Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionNatural killer (NK) cells are cytotoxic lymphocytes critical to human immunity. Previous studies showed correlations between NK cell function and blood glucose concentrations. The purpose of the present study was to assess the NK cell activity and various metabolic parameters in people with type 2 diabetes, prediabetes and normal glucose tolerance. MATERIALS AND

methodsA total of 49 participants were enrolled in the study. Anthropometric and biochemical parameters including age, sex, body mass index, smoking status, blood pressure, fasting plasma glucose, C-peptide, insulin, glycated hemoglobin, total cholesterol, triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were assessed. The 75 g oral glucose tolerance test was carried out for 2-h postload glucose level. Homeostatic model assessment was calculated for insulin resistance and β-cell function. NK cell activity was measured by detecting the circulating interferon-gamma level secreted from NK cells.

resultsNK cell activity was lower in patients with type 2 diabetes (768.01 ± 650.35) compared with those with prediabetes (2,396.08 ± 653.76, P < 0.001) and normal glucose tolerance (2,435.31 ± 633.22, P < 0.001). In patients with type 2 diabetes, there was a significant inverse linear relationship between NK cell activity and fasting plasma glucose, glycated hemoglobin, and 2-h postload glucose level (all P < 0.001). Multiple regression analysis showed glycated hemoglobin to be an independent predictor of NK cell activity in patients with type 2 diabetes.

conclusionsCompared with individuals with normal glucose tolerance or prediabetes, type 2 diabetes patients have a reduced NK cell activity, and it is significantly related to glucose control.

Indexed as

BiomarkersBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlycated HemoglobinHumansKiller Cells, NaturalMaleMiddle AgedPrediabetic StatePrognosisBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHyperglycemiaNatural killer cell activityType 2 diabetes mellitus

Identifiers

PMID30618112
PMCPMC6717814
OpenAlexW2911146993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.